Summary
Elevated concentrations of proinsulin-like molecules, other than insulin, may be associated with abnormalities of cardiovascular risk factors, promoting atherogenesis and thrombosis. Using specific assays we examined the relationship of levels of insulin, intact proinsulin and des-31,32 proinsulin to blood pressure, lipids, fibrinogen, factor VII and albumin excretion rate in 270 europids with normal glucose tolerance. After correcting for age and body mass index, fasting and 2-h insulin concentrations were significantly associated with those of total and LDL-cholesterol (r=0.18–0.22), HDL-cholesterol (both r=−0.20) and triglycerides (r=0.21 and 0.18), but not with blood pressure. Concentrations of intact and des-31,32 proinsulin showed significant associations with those of total and LDL-cholesterol (r=0.20–0.23), HDL-cholesterol (r=−0.31 and −0.32) and triglycerides (r=0.22 and 0.26). Fasting insulin and intact proinsulin concentrations were significantly associated with fibrinogen (r=0.15 and 0.18). Concentrations of proinsulin-like molecules comprised less than 10% of all insulin-like molecules, and so were calculated not to influence previously described relationships between insulin concentrations and cardiovascular risk factors measured using non-specific assays. In multiple regression analyses des-31,32 proinsulin concentration was more strongly associated with those of HDL-cholesterol (negatively), LDL-cholesterol and triglycerides than fasting insulin concentrations, while intact proinsulin replaced insulin concentrations in their relationships with fibrinogen. Our results show correlations between dyslipidaemia and proinsulin-like molecules at concentrations at which biological, insulin-like, activity appears unlikely. We also show relationships between LDL-cholesterol and fibrinogen and the proinsulin-like molecules. These results suggest that a causal relationship mediated by hyperinsulinaemia and insulin resistance is unlikely.
Article PDF
Similar content being viewed by others
Abbreviations
- PAI-1:
-
Plasminogen activator inhibitor-1
- PI:
-
proinsulin
- CV:
-
coefficient of variation
References
Laakso M, PyörÄlÄ K, Voutilainen E, Marniemi J (1987) Serum lipids and lipoproteins in middle-aged non-insulin dependent diabetic and non-diabetic subjects. Am J Epidemiol 125: 611–621
Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK (1988) Hyperinsulinaemia, upper body obesity and cardiovascular risk factors in non-diabetics. Metabolism 37: 338–345
Nagi DK, Hendra TJ, Ryle AJ Cooper TM, Temple RC, Clark PMS, Schneider AE, Hales CN, Yudkin JS (1990) The relationships of concentrations of insulin, intact proinsulin and 32–33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 33: 532–537
Temple RC, Clark P, Schneider A, Nagi DK, Hendra TJ, Yudkin JS, Hales CN (1990) Radioimmunoassay may over-estimate insulin in non-insulin-dependent diabetics. Clin Endocrinol 32: 689–693
Haffner SM, Mykkanen L, Stern MP, Valdez RA, Heisserman JA, Bowsher RR (1993) Relationship of proinsulin and insulin to cardiovascular risk factors in non diabetic subjects. Diabetes 42: 1297–1302
Grootenhuis PA, Mooy JM, Popp-Snijders C, Bouter LM, Heine RJ (1993) Proinsulin-like molecules in relation to blood lipids and blood pressure in a general Caucasian population. Diabetologia 36: [Suppl 1] A71 (Abstract)
Gould MM, Mohamed-Ali V, Goubet SA, Yudkin JS, Haines AP (1993) Microalbuminura: associations with height and sex in non-diabetic subjects. BMJ 306: 240–242
WHO study group (1985) Diabetes mellitus. WHO Technical Report Series 727
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein-cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499–502
Chesham J, Anderton SW, Kingdon CFM (1986) Rapid competitive enzymoimmunoassay for albumin in urine. Clin Chem 32: 669–671
Mohamed-Ali V, Yudkin JS (1992) An end-point amplified immunoenzymometric assay (IEMA) specific for human insulin. Clin Sci 82: [Suppl 27] 4P
Mohamed-Ali V, Yudkin JS (1993) Simple and highly sensitive microplate immunoradiometric assays (IRMAs) for intact proinsulin and des 31,32 proinsulin. Diabet Med 10: [Suppl 1] P67
Sobey WJ, Beer SF, Carrington CA et al. (1989) Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65–66 split and 32–33 split proinsulin. Biochem J 260: 535–541
Johannson A, Stanley CJ, Self CH (1985) A fast, highly sensitive colorimetric enzyme immunoassay system demonstrating benefits of enzyme amplifications in clinical chemistry. Clin Chim Acta 148: 119–124
Reaven GM (1985) Role of insulin resistance in human disease. Diabetes 37: 1595–1607
Ferrannini E, Haffner SM, Mitchell BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416–422
De Fronzo RA, Cooke CR, Andres R, Faloona GR, Davies PJ (1975) The effect of insulin on renal handling of sodium, potassium, calcium and phosphate in man. J Clin Invest 55: 845–855
Landsberg L (1986) Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system and adaptive thermogenesis. Q J Med 61: 1081–1090
Frayn KN, Coppack SW (1992) Insulin resistance, adipose tissue and coronary heart disease. Clin Sci 82: 1–8
Modan M, Halkin H, Lusky A, Segal P, Fuchs Z, Chetrit A (1988) Hyperinsulinaemia is characterized by jointly disturbed plasma VLDL, LDL and HDL levels. Arteriosclerosis 8: 227–236
Cigolini M, Seidell JC, Charzewska J et al. (1991) Fasting serum insulin in relation to fat distribution, serum lipid profile and blood pressure in European women: the European fat distribution study. Metabolism 8: 781–787
Orchard FJ, Becker DJ, Bates M, Kuller LH, Drash AL (1983) Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 118: 326–337
Sheu WHH, Shieh SM, Fuh MMT, Shen DD, Jeng CY, Chen YD, Reaven GM (1993) Insulin resistance, glucose intolerance and hyperinsulinaemia. Hypertriglyceridaemia versus hypercholesterolaemia. Arteriosclerosis Thromb 13: 367–370
Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti GC (1993) Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342: 883–887
Groop L, Ekstrand A, Forsblom C, Widén E, Groop PH, Teppo AM, Eriksson J (1993) Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulindependent) diabetes mellitus. Diabetologia 36: 642–647
Haffner SM, Stern MP, Gruber KK, Hazuda HP, Mitchell BD, Patterson GK (1990) Microalbuminuria — potential marker for increased cardiovascular risk factors in non diabetic subjects? Arteriosclerosis 10: 727–731
Winocour PH, Harland JOE, Millar JP, Laker MF, Alberti KGMM (1992) Microalbuminuria and associated cardiovascular risk factors in the community. Arteriosclerosis 93: 71–81
Woo J, Cocknam CS, Swaminathan R, Lau E, Chan A, Cheung R (1992) Microalbuminuria and other cardiovascular risk factors in non-diabetic subjects. Int J Cardiol 37: 345–350
Krentz AJ, Clark PMS, Cox L, Nattrass M (1993) Hyperinsulinaemia in impaired glucose tolerance. Clin Sci 85: 97–100
Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY (1990) Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39: 104–111
HaffnerSM, MykkanenL, ValdezRA, SternMP (1994) Evaluation of two insulin assays in insulin resistance syndrome (syndrome X). ArteriosclerThromb 14: 1430–1437
Jain SK, Nagi DK, Slavin BM, Lumb PJ, Yudkin JS (1993) Insulin therapy in non-insulin-dependent diabetic subjects suppresses concentrations of proinsulin-like molecules and plasminogen activator inhibitor independently from glycaemic control. Diabet Med 10: 27–32
Yudkin JS (1993) Circulating proinsulin-like molecules. J Diab Comp 7: 113–123
Barker DJP (ed) (1992) Fetal and infant origins of adult disease. BMJ Press London
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mohamed-Ali, V., Gould, M.M., Gillies, S. et al. Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects — evidence against a modulating role for insulin. Diabetologia 38, 1110–1116 (1995). https://doi.org/10.1007/BF00402183
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00402183